PMID: 7517523May 1, 1994Paper

Short AV interval VDD pacing does not prevent tilt induced vasovagal syncope in patients with cardioinhibitory vasovagal syndrome

Pacing and Clinical Electrophysiology : PACE
M PetersenK ] Rift K [corrected to Riff

Abstract

Eleven subjects (mean age 50 years, range 33-71 years), who had previously received permanent dual chamber pacemakers for cardioinhibitory vasovagal syncope, underwent paired Westminster protocol tilt tests, one with short AV delay VDD pacing and one without pacing, to test the hypothesis that continuous ventricular pacing would prevent the cardiac initiation of vasovagal syncope. Nine (82%) of the paced tilts produced positive vasovagal outcomes compared with seven (64%) of the unpaced tilts. No important differences in the heart rate or blood pressure behavior during tilt or the time to positive vasovagal outcomes were observed between the paired tilts. There was more accelerated syncope/presyncope once symptoms had developed during the paced tilts of subjects in whom both study tilts were positive, although this did not reach statistical significance (P = 0.054). This study shows that atrial synchronous ventricular pacing does not prevent the initiation, or progression, of tilt induced vasovagal syncope in predisposed subjects.

References

Jan 1, 1978·Pacing and Clinical Electrophysiology : PACE·S OgawaB V Berkovits
Jul 1, 1978·The American Journal of Cardiology·C AlicandriV Morant
Oct 1, 1992·Pacing and Clinical Electrophysiology : PACE·B P GrubbL Elliott
Sep 11, 1992·The American Journal of Cardiology·F A FishD W Benson
Apr 1, 1992·The American Journal of Cardiology·B P GrubbL Elliot
May 15, 1992·The American Journal of Cardiology·R SheldonS Killam
Nov 1, 1991·Clinical Science·J J van LieshoutD L Eckberg
May 1, 1990·Pacing and Clinical Electrophysiology : PACE·A P FitzpatrickR Sutton
Jan 1, 1991·Pacing and Clinical Electrophysiology : PACE·A FitzpatrickR Sutton
Jan 1, 1991·Journal of the American College of Cardiology·A P FitzpatrickR Sutton
Jun 1, 1990·The American Journal of Cardiology·S MilsteinW J Reyes
Nov 1, 1986·Pacing and Clinical Electrophysiology : PACE·K AusubelS Furman
Feb 9, 1989·The New England Journal of Medicine·F M Abboud
Sep 1, 1987·Journal of the American College of Cardiology·M R ZileW H Gaasch
Sep 1, 1987·The American Journal of Cardiology·M WishA I Cohen
Oct 1, 1985·International Journal of Cardiology·D W Sapire, A Casta
Feb 1, 1968·The American Journal of Cardiology·P SametW H Bernsein
May 14, 1932·British Medical Journal·T Lewis

❮ Previous
Next ❯

Citations

Jul 1, 1996·Journal of the American College of Cardiology·D G BendittD L Wood
Mar 28, 2003·International Journal of Cardiology·Dursun AlehanSencan Ozme
Apr 1, 1995·Pacing and Clinical Electrophysiology : PACE·D KosinskiP Temesy-Armos
Mar 1, 1997·Pacing and Clinical Electrophysiology : PACE·M E Petersen, R Sutton
Sep 1, 1995·Journal of Cardiovascular Electrophysiology·J S Sra, M Akhtar
Jul 1, 1995·Journal of Cardiovascular Electrophysiology·R Sutton, M E Petersen
Feb 28, 2001·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·D KosinskiS Frederick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.